Quilizumab (INN) is a humanized monoclonal antibody designed for the treatment of asthma.Statement On A Nonproprietary Name Adopted By The USAN Council - Quilizumab, American Medical Association. It binds to IGHE.

This drug was developed by Genentech.

References